Literature DB >> 6421484

The structure of an R-type oligosaccharide core obtained from some lipopolysaccharides of Neisseria meningitidis.

H J Jennings, K G Johnson, L Kenne.   

Abstract

The main structure of a lipopolysaccharide R-type core oligosaccharide common to a number of different strains of Neisseria meningitidis has been elucidated. Methylation analysis, specific degradations, and nuclear magnetic resonance spectroscopic analysis of the dephosphorylated cores indicated that they all have the following structure. (formula see text) The determinants responsible for the L3, L7, and L9 meningococcal lipopolysaccharide serotypes are situated in this oligosaccharide.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6421484     DOI： 10.1016/0008-6215(83)84020-8

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN： 0008-6215            Impact factor:   2.104


  32 in total

1.  Phosphorylation of the lipid A region of meningococcal lipopolysaccharide: identification of a family of transferases that add phosphoethanolamine to lipopolysaccharide.

Authors:  Andrew D Cox; J Claire Wright; Jianjun Li; Derek W Hood; E Richard Moxon; James C Richards
Journal:  J Bacteriol       Date:  2003-06       Impact factor: 3.490

2.  Development, characterization, and functional activity of a panel of specific monoclonal antibodies to inner core lipopolysaccharide epitopes in Neisseria meningitidis.

Authors:  Margaret Anne J Gidney; Joyce S Plested; Suzanne Lacelle; Philip A Coull; J Claire Wright; Katherine Makepeace; Jean-Robert Brisson; Andrew D Cox; E Richard Moxon; James C Richards
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  Structure of the sugar-phosphate moiety of lipid A from lipooligosaccharide of Neisseria meningitidis group B, strain BC5S No. 125. Hydrolytic stability of phosphate and pyrophosphate substituents.

Authors:  V L L'vov; I K Verner; A V Rodionov; A V Ignatenko; A S Shashkov
Journal:  Arch Microbiol       Date:  1992       Impact factor: 2.552

4.  The structure of the L9 immunotype lipooligosaccharide from Neisseria meningitidis NMA Z2491.

Authors:  Biswa Choudhury; Charlene M Kahler; Anup Datta; David S Stephens; Russell W Carlson
Journal:  Carbohydr Res       Date:  2008-09-02       Impact factor: 2.104

5.  Immune responses against major outer membrane antigens of Neisseria meningitidis in vaccinees and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial.

Authors:  E Wedege; E A Høiby; E Rosenqvist; G Bjune
Journal:  Infect Immun       Date:  1998-07       Impact factor: 3.441

6.  Nonopsonic phagocytosis of group C Neisseria meningitidis by human neutrophils.

Authors:  M M Estabrook; D Zhou; M A Apicella
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

Review 7.  Lipopolysaccharide nomenclature--past, present, and future.

Authors:  P J Hitchcock; L Leive; P H Mäkelä; E T Rietschel; W Strittmatter; D C Morrison
Journal:  J Bacteriol       Date:  1986-06       Impact factor: 3.490

8.  Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity.

Authors:  E E Moran; B L Brandt; W D Zollinger
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 9.  Meningococcal lipopolysaccharides: virulence factor and potential vaccine component.

Authors:  A F Verheul; H Snippe; J T Poolman
Journal:  Microbiol Rev       Date:  1993-03

10.  Conjugation of meningococcal lipopolysaccharide R-type oligosaccharides to tetanus toxoid as route to a potential vaccine against group B Neisseria meningitidis.

Authors:  H J Jennings; C Lugowski; F E Ashton
Journal:  Infect Immun       Date:  1984-01       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.